Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MilliporeSigma
Pharma
MilliporeSigma plugs €62M into new quality control building
Despite some growing pains in the post-COVID era, Merck KGaA's MilliporeSigma continues to make a splash with big production moves this year.
Fraiser Kansteiner
Jun 14, 2024 10:00am
Merck KGaA buys out gene therapy specialist Mirus Bio for $600M
May 23, 2024 8:35am
Merck KGaA's MilliporeSigma helps expose fraud scheme to DOJ
May 22, 2024 12:48pm
Merck KGaA's CDMO sales down 17%, company projects turnaround
May 15, 2024 11:18am
Merck KGaA's MilliporeSigma makes €300M pledge at new Korea site
Mar 21, 2024 1:22pm
MilliporeSigma christens €28M pair of mRNA production plants
Sep 26, 2023 12:38pm
